New Alzheimer’s drug therapy from Eli Lillly wins FDA approval
Eli Lilly & Co.’s Alzheimer’s therapy was cleared within the US because the second drug to sluggish development of the ...
Eli Lilly & Co.’s Alzheimer’s therapy was cleared within the US because the second drug to sluggish development of the ...
Unlock the Editor’s Digest free of chargeRoula Khalaf, Editor of the FT, selects her favorite tales on this weekly e-newsletter.London ...
The Swiss-American ophthalmology firm can pay $60 million instantly and as much as $335 million with milestone funds for the ...
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) and Israeli firm Biolojic Design have signed a collaboration settlement. Teva ...
Welcome to Webbizmarket The goal of Webbizmarket is to give you the absolute best news sources for any topic! Our topics are carefully curated and constantly updated as we know the web moves fast so we try to as well.
Copyright © 2023 Webbizmarket.com | All Rights Reserved.